- Home
- Equipment
- asia middle east
- transdermal
Refine by
Transdermal Equipment Supplied In Asia Middle East
6 equipment items found
Manufactured by:Frontier Biotechnologies Inc. based inNanjing, CHINA
FB3001, a new transdermal topical patch, is a musculoskeletal joint pain treatment, currently under clinical development. Through collaboration with ABsize, FB3001's Phase II clinical trial for treating lower back pain has been completed in the United States. ...
Manufactured by:Troikaa Pharmaceuticals Ltd. based inAhmedabad, INDIA
Dynapar QPS is the world's first Transdermal preparation of Diclofenac, which provides excellent pain relief after topical application, by enhancing the penetration of Diclofenac through the skin. Dynapar QPS is backed by proof of concept pharmacokinetic studies as well as clinical ...
Manufactured by:Uniproma based inDuesseldorf, GERMANY
Arelastin W is both safe and stable, with powerful antioxidant properties that provide excellent anti-wrinkle effects. Using exclusive non-invasive transdermal technology, Arelastin W penetrates deep into the dermis, effectively repairing damaged skin. Additionally, Arelastin W significantly stimulates cell proliferation and exhibits excellent ...
Manufactured by:Uniproma based inDuesseldorf, GERMANY
Arelastin P is both safe and stable, with powerful antioxidant properties that provide excellent anti-wrinkle effects. Using exclusive non-invasive transdermal technology, Arelastin P penetrates deep into the dermis, effectively repairing damaged skin. Additionally, Arelastin P significantly stimulates cell proliferation and exhibits excellent ...
Manufactured by:Life Pharma Chem based inRajkot, INDIA
Life Pharma Chem is a renowned pharmaceutical company that deals in the production of PVP K30 (povidone). The company has carved a niche for itself in this domain and is known for its high-quality products. It follows stringent quality control measures to ensure that only the best products reach the end ...
Manufactured by:Lumosa Therapeutics Co., Ltd. based inTaipei, TAIWAN
The Global Burden of Disease Study suggested that there are 700 million cases of chronic kidney disease (CKD) worldwide. 50% of patients with CKD, and 90% of dialysis patients have uremic pruritus, a condition that have negative physiological, psychological, and social impacts on the patients. The condition severely interferes with patients’ sleeping patterns that devastates ...